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ABSTRACT
Background and Aims Admission to a smoke-free setting presents a unique opportunity to encourage smokers to quit.
However, risk of relapse post-discharge is high, and little is known about effective strategies to support smoking cessation
following discharge. We aimed to identify interventions that maintain abstinence following a smoke-free stay and deter-
mine their effectiveness, as well as the probable effectiveness of behaviour change techniques (BCTs) used in these inter-
ventions. Methods Systematic review and meta-analyses of studies of adult smokers aged ≥ 18 years who were
temporarily or fully abstinent from smoking to comply with institutional smoke-free policies. Institutions included prison,
inpatient mental health, substance misuse or acute hospital settings. A Mantel–Haenszel random-effects meta-analysis of
randomized controlled trials (RCTs) was conducted using biochemically verified abstinence (7-day point prevalence or con-
tinuous abstinence). BCTs were defined as ‘promising’ in terms of probable effectiveness (if BCT was present in two ormore
long-term effective interventions) and feasibility (if BCT was also delivered in ≥ 25% of all interventions). Results Thirty-
seven studies (intervention n = 9041, control n = 6195) were included: 23 RCTs (intervention n = 6593, control
n = 5801); three non-randomized trials (intervention n = 845, control n = 394) and 11 cohort studies (n = 1603).
Meta-analysis of biochemically verified abstinence at longest follow-up (4 weeks–18 months) found an overall effect in fa-
vour of intervention [risk ratio (RR) = 1.27, 95% confidence interval (CI) = 1.08–1.49, I2 = 42%]. Nine BCTs (including
‘pharmacological support’, ‘goal-setting (behaviour)’ and ‘social support’) were characterized as ‘promising’ in terms of
probable effectiveness and feasibility. Conclusions A systematic review and meta-analyses indicate that behavioural
and pharmacological support is effective in maintaining smoking abstinence following a stay in a smoke-free institution.
Several behaviour change techniques may help to maintain smoking abstinence up to 18 months post-discharge.
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INTRODUCTION
Smoking remains a leading cause of mortality and morbid-
ity world-wide [1]. Smoking prevalence in the general pop-
ulation in England has steadily declined, but recent data
indicate that prevalence remains approximately 50%
higher among people with mental health conditions in
the United Kingdom [2]. Smokers with mental health con-
ditions aremore likely to experience greater dependence on
smoking, and the long-term quit rates among this popula-
tion are lower [2–5]. However, people with mental health
conditions are just as motivated to quit as those in the gen-
eral population [2,6], but are less likely to receive the re-
quired support compared to smokers without mental
health conditions [3].
Smoking prevalence can reach 80% in inpatient, sub-
stance misuse and prison settings, widening inequalities
in morbidity and mortality [7]. Efforts to address this
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inequality have been made, including the implementation
of smoke-free policies in many health and care residential
settings, and delivery of smoking abstinence and cessation
support for smokers during their stay [8]. These settings of-
ten act as an individual’s residence for the duration of their
stay, and thus can provide a unique opportunity of absti-
nence to initiate long-term change to reduce morbidity
and mortality [7].
Evidence suggests individuals can successfully remain
abstinent during their smoke-free inpatient stay when be-
havioural and/or pharmacological support is offered [7].
However, where a smoke-free stay resulted in temporary
smoking abstinence or cessation, the risk of relapse
post-discharge is high [9,10]. Relapse to smoking
post-discharge often occurs quickly, and the vast majority
of smokers appear to return to smoking on the same day
of discharge [11,12]. Therefore, it is vital to provide support
post-discharge to prevent relapse; however, little is known
about effective strategies to prevent return to previous
smoking behaviours following discharge from a range of
settings [7].
Traditionally, systematic reviews and meta-analyses
aim to investigate the effectiveness of interventions,
and whether or not they ‘work’ for the intended popula-
tion [7,13]. However, reviews of non-pharmacological,
behavioural interventions for smoking cessation often
find wide variation in effect sizes [14]. Behaviour change
interventions (including smoking cessation behavioural
support) can be designed and delivered in various ways.
These interventions are also typically complex, compris-
ing multiple, interacting component behaviour change
techniques (BCTs) [15,16], defined as ‘active
components of an intervention designed to change
behaviour’ [17]. Examples of well-known BCTs include
setting goals, action planning and providing feedback
on behaviour. To understand what influences the
effectiveness of interventions and further identify what
makes one intervention more effective than another, it
is useful to investigate which component BCTs are likely
to be associated with effectiveness.
Taxonomies of BCTs have been developed to enable the
clear specification of intervention content [18]. The be-
haviour change technique taxonomy version 1 (BCTTv1)
[19] contains 93 discrete BCTs, each with a consistent la-
bel and definition (divided into 16 clusters), and is
intended to be applicable across behavioural domains.
The BCTTv1 has been increasingly applied in systematic
reviews to specify or describe the content of behavioural
interventions using a common language and explore the
association with outcomes of specific intervention compo-
nents [7,20,21]. Although a previous systematic review
on maintaining smoking abstinence after a smoke-free
stay conducted by Brose et al. [7] applied the BCTTv1 to
specify the content of interventions, it did not link BCTs
to outcomes in order to identify potentially effective or
‘promising’ BCTs. Rather, the authors identified BCTs that
were most prevalent within the included interventions, de-
livered in mental health settings, substance abuse centres
or prisons. The evidence base was relatively small, and in-
cluded 10 quantitative studies with a limited range of in-
terventions. This is an area of emerging research, with a
range of recent quantitative and qualitative studies investi-
gating the subject in a variety of relevant settings, includ-
ing acute hospitals, which had not been part of the
previous review [7].
Effective health-care interventions require an under-
standing of the broader context of the problem (e.g. the
social and environmental context, and non-contextual in-
fluences on behaviour such as knowledge, consequences
and motivation) [22]. The theoretical domains framework
(TDF) is an integrative theoretical model that synthesizes
main behaviour change constructs across key theories
into 14 domains, such as ‘knowledge’ or ‘goals’ [23]. It
has been used to inform the development of behaviour
change interventions [24], including smoking cessation
support [25]. The application of the TDF can help to
highlight in which domains the factors associated with
the success or failure to smoking cessation lie, and help
to identify BCTs that might effectively target these. Addi-
tionally, understanding the experiences, needs and per-
ceptions of participants and staff is important to
ensuring future interventions and policy align with the
preferences of the intended population for smoking
cessation.
The present review updates and complements the
existing knowledge base [2] by examining pharmacological
or behavioural interventions delivered during the stay
and/or post-discharge following a stay in a smoke-free
setting, including mental health and substance abuse
settings, prisons and acute hospital settings. Qualitative
studies were included to explore stakeholders’ experiences
with interventions. Therefore, research aims were to
determine:
1 What interventions (behavioural and/or pharmacologi-
cal) have been provided tomaintain smoking abstinence
following a stay at a smoke-free setting, and which BCTs
have been delivered within these interventions.
2 The effectiveness of interventions to maintain smoking
abstinence following a stay at a smoke-free setting,
and which component BCTs are identified as
‘promising’; the factors associated with/predictors of
success or failure of post-discharge smoking cessation
or relapse prevention interventions.
3 Participant and/or staff experiences, needs or percep-
tions related to supporting smoking cessation or relapse
prevention following a stay at a smoke-free setting.
4 The quality of included studies and potential publication
bias.
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METHODS
We report methodology in accordance with the Preferred
Reporting Items for Systematic Reviews and
Meta-analyses (PRISMA) guidelines [26], following a
pre-registered International Prospective Register of System-
atic Reviews (PROSPERO) protocol [CRD42020170275].
Search strategy
MEDLINE, EMBASE, PsycINFO, CINAHL and Web of
Science were searched up to February 2020. The search
strategy published by Brose et al. [7] was adapted to include
additional terms relating to relevant settings (e.g. acute
hospitals), relevant study types (qualitative studies) and
outcomes (e.g. perceptions, experiences, factors associated
with/predictors of success or failure of smoking cessation
interventions). Searches were limited to studies in English
involving adults. All the studies included in the review con-
ducted by Brose et al. [7] were included in the current re-
view. The full search strategy is presented in Supporting
information, Table S1. Endnote X9 was used to record pub-
lications at all stages of the selection process (Fig. 1). Titles
and abstracts were screened independently by two authors
(E.S. and L.H.) to ensure consensus. If there was a disagree-
ment, studies were included in the full-text review. Full-text
screening of included articles was undertaken indepen-
dently by two authors (E.S. and L.H.), with disagreements
settled by a third author (E.R.).
Inclusion criteria
Studies were identified for inclusion based on the popula-
tion, intervention, comparator and outcome (PICO)
method for eligibility. Randomized controlled trials (RCTs)
(including feasibility and pilot trials), observational cohort
studies and surveys or qualitative studies were considered.
Population
Studies including adult smokers ≥ 18 years of age who
were temporarily or fully abstinent from smoking to comply
with institutional smoke-free policies (those in mental
health services, treatment for substance abuse, prisoners/
offenders, or acute hospital wards) and were followed-up
post-dischargewere included. Biochemical validation of ab-
stinence was not a requirement for study inclusion.
Intervention
Intervention comprised studies that described or evaluated
behavioural and/or pharmacological interventions to
Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) diagram of paper selection process
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support smoking cessation during the stay, post-discharge
or a combination of both.
Comparator
A control comparator was not necessary for inclusion in
this review. Studies with or without the following controls
were considered: no treatment control groups, placebo,
waiting-list control, normal practice or any other interven-
tion described by the authors as a comparator.
Outcomes
Outcomes included RCTs (including randomized feasibility
studies and pilot trials) and cohort studies that reported
smoking abstinence, either via self-report and/or validated
by biochemical verification at any time-point post-dis-
charge. Qualitative studies were included if they reported
participant and/or staff experiences, needs or perceptions
relating to supporting smoking cessation following a stay
at a smoke-free setting.
Exclusion criteria
Studies were excluded if: (1) settings did not have a
smoke-free policy; (2) smoke-free policies and/or smoking
cessation interventions were described or evaluated, but
did not include a stay in a smoke-free setting; (3) settings
had a smoke-free policy but did not implement any inter-
vention to support smoking cessation; or (4) they were sys-
tematic reviews or not original research.
Outcome measures
i Biochemically verified smoking abstinence at longest
follow-up.
ii Modifiable factors associated with/predictors of success
or failure of smoking cessation interventions (e.g. par-
ticipant motivation, participant fear of failure).
iii Participant/staff experiences, needs or perceptions re-
lated to supporting smoking cessation (e.g. experiences,
needs or perceptions of receipt or delivery of an
intervention).
Data extraction
Using a pre-defined table, relevant data were extracted
from all studies by two authors (E.S. and L.H.). Published
descriptions of the content of smoking cessation interven-
tions were coded using the BCTTv1 [18]. BCTs were coded
for the intervention as a whole, and also separated for
those delivered during the smoke-free stay and those deliv-
ered post-discharge/release. As current guidance for
reporting of trials and their interventions recommends that
both experimental and comparator interventions are re-
ported in similar detail [27–29], BCTs were also coded in
the control or comparator arm (e.g. standard care/other
interventions) for studies with a comparator. All articles
were coded independently by two researchers (E.S. and
L.H.), and included the involvement of a behaviour change
expert with experience in using the BCTTv1 and delivering
training in its application (F.L.). A + and ++ system was
not applied to coding, as this system is often used in initial
training for use of the BCTTv1, but not always during cod-
ing analyses. Instead, the researchers were cautious to not
infer a presence of a BCT, basing the coding on reported
content in intervention descriptions only, and any in-
stances of uncertainty were discussed as a team.
Modifiable and non-modifiable factors associated with
success or failure of smoking cessation interventions (as
identified by the study authors) were extracted.
Non-modifiable factors were common covariates (e.g. par-
ticipant demographics and nicotine dependence). Modifi-
able factors (e.g. plans to not smoke, desire to quit) were
coded to the TDF. All articles were coded independently
by one author and subsequently coded by a second author,
with disagreements resolved through discussion with a
third author.
Quality assessment
Version 11 of the mixed methods appraisal tool (MMAT)
[30] was used to assess each study. The MMAT was devel-
oped for complex systematic reviews, permitting quality
appraisal for a range of methodological studies. The tool’s
validity and reliability have been established [31]. Two au-
thors independently assessed and rated the studies and
compared scores. Disagreements were resolved through
discussion.
Data synthesis
For RCTs, aMantel–Haenszel meta-analysis was conducted
using RevMan version 5.4 [32]. Heterogeneity between
study outcomes was assessed using the I2 statistic, suitable
for smaller meta-analyses [33]. Due to the likelihood of sig-
nificant heterogeneity, a random-effects model was used.
Post-hoc subgroup analyses to separate studies by those
with a follow-up length of fewer than 6 months and those
with a follow-up length of more than 6 months were also
conducted. For all meta-analyses, participants lost to fol-
low-up were treated as non-abstinent, except those who
were reported as deceased [34]. Publication bias was
assessed using funnel plots. Where visual inspection indi-
cated potential funnel plot asymmetry, Egger’s regression
intercept, used to quantify publication bias [35], was used
to investigate this.
BCTs were defined as ‘promising’ in terms of probable
effectiveness if the technique was present in at least two
long-term effective interventions [36], defined as those
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reporting statistically significant (P < 0.05, where re-
ported) differences in smoking abstinence between inter-
vention and control groups at a 6-month follow-up point
or later (either biochemically validated or by self-report).
Subsequently, the BCTs defined as ‘promising’ in terms of
probable effectiveness were defined as ‘promising’ in terms
of feasibility if they were also delivered in ≥ 25% interven-
tions. By using this approach, BCTs were considered in
terms of their overall frequency and allowed identification
of techniques that were most likely to be feasible, accept-
able and fit for purpose [20].
For modifiable factors associated with/predictors of suc-
cess or failure, deductive analysis guided by the domains of
the TDF was conducted by coding extracted factors to the
domains they were judged to best represent. Data regard-
ing the perceptions, needs or experiences of participants
and staff were summarized in a narrative synthesis.
Additional information (treatment manuals or treat-
ment protocols) was requested from the authors of all in-
cluded studies. Detailed intervention descriptions were
provided by six authors, and information was also obtained
from the supplementary information provided by Brose
et al. [7]. For authors who could not be contacted, or where
additional information was not available from Brose et al.




Research questions were clearly stated in all the studies,
and methods that were appropriate to answer the research
questions were used. Themajority provided sufficient infor-
mation to allow MMAT assessment, and were considered
as being of high quality. Those lacking the required infor-
mation included eight RCTs where it was not possible to as-
certain whether the outcome assessors were blinded to the
intervention, and one which provided insufficient informa-
tion in relation to the rate of attrition. Full details of the
studies assessed are provided in Supporting information,
Table S2.
Description of studies
The search identified 15 081 records; 37 studies (interven-
tion n = 9041, control n = 6195) were included in the re-
view (Fig. 1). Twenty-three studies [10,37–58] were RCTs
(intervention n = 6593, control n = 5801). Three studies
[59–61] were trials, but adopted a non-randomized design
(intervention n = 845, control n = 394). In one study, pa-
tients decided which group they wanted to participate in
[61], but the remaining studies did not provide further in-
formation regarding how participants were allocated to
each group [59,60]. Eleven studies [9,62–71] used a
cohort design (n = 1603). No qualitative studies were eligi-
ble for inclusion, primarily due to participants not staying
in a smoke-free setting or settings not reporting a
smoke-free policy. Therefore, for the fourth research ques-
tion, information regarding participant experiences, needs
or perceptions were obtained from data provided in other
study designs where available.
The origin of studies varied (see Supporting informa-
tion, Table S3), with the majority being conducted in the
United States (n = 25). The remaining studies were
conducted in Australia (n = 5), Brazil (n = 2) and the
United Kingdom, Tunisia, France, Canada and Greece
(n = 1, respectively). Most studies were conducted in
acute hospitals (n = 20), followed by mental health
inpatient settings (n = 9), substance abuse treatment
settings (n = 5) and prisons (n = 3).
Of studies reporting average length of stay (n = 20), the
longest stay was in prison settings, reporting an average of
1.5 and 1.2 years [10,70]. For non-prison settings, the lon-
gest average length of stay was 90 days in a substance
abuse setting [68,69]. Study follow-up periods ranged from
3 weeks [70,71] to 18 months [49].
Intervention characteristics
Interventions varied in frequency, content and mode of de-
livery (see Supporting information, Table S3). For studies in
acute hospital settings (n = 20), the majority of interven-
tions was delivered by hospital staff or smoking cessation
practitioners. Five studies [39,41,43,47,48] involved re-
searchers in intervention delivery. For studies in mental
health or substance abuse settings (n = 14), the majority
of the interventions were delivered by mental health or
substance use professionals, with the exception of three
studies [49,54,67] in which the interventions were deliv-
ered by researchers. Three interventions delivered in
prisons [10,70,71] were facilitated by researchers.
Post-discharge interventions were included in
the majority of the trials (n = 23), with the exception
of three [38,39,45] and five cohort studies
[9,61,63,66,67]. Telephone calls were used in 14 studies
[10,41,42,48,50–52,54–56,58,60,61,67], ranging from
one to 14 calls at time-points between 1 day and
9 months post-discharge. Three studies delivered a
computer-assisted intervention 3 and 6 months
post-discharge [43,47,49], and one intervention
supported patients via text message during the first
8–15 days post-discharge [41].
Trials used varying controls, including usual care
[44,49,54]; enhanced treatment as usual [47]; brief
cessation interventions [39]; and a health-related,
non-smoking cessation intervention matched for fre-
quency and duration [10].
Smoking cessation following smoke-free stay 5
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Biochemically verified smoking abstinence
Four trials [40,42,55,58] were excluded from the meta-
analysis; Chui et al. [40] did not report biochemically
verified abstinence; Cummins et al. [42] reported a
30-day abstinence rate validated by cotinine analysis, but
did not report the results separately for the control group
versus the three intervention arms. Two trials reported bio-
chemically verified abstinence in participant subgroups, as
opposed to intervention/control arm [55,58].
The meta-analysis of smoking abstinence at longest re-
spective follow-up (4 weeks to 18months) found an overall
effect in favour of intervention [risk ratio (RR) = 1.27, 95%
confidence interval (CI) = 1.08–1.49] (Fig. 2). Overall,
14.0% participants in the intervention groups achieved ab-
stinence compared with 11.7% in the control groups.
However, substantial heterogeneity was indicated for the
meta-analysis.
To explore heterogeneity, subgroup analyses were con-
ducted to separate studies by those with a follow-up length
of fewer than 6 months (Fig. 3a) and those with a
follow-up length of more than 6 months (Fig. 3b).
The subgroup analysis of smoking abstinence in studies
with a follow-up length of fewer than 6 months found an
overall effect in favour of intervention (RR = 1.30, 95%
CI = 1.00–1.68) (Fig. 3a), but still indicated substantial
heterogeneity. Those with a follow-up length of more than
6 months found an overall effect in favour of intervention
(RR = 1.23, 95% CI = 1.02–1.48) (Fig. 3b), and indicated
less heterogeneity. Therewas no difference in the risk ratios
for those with a follow-up length of fewer than 6 months
and those with a follow-up length of more than 6 months,
based on the overlapping CIs.
Subgroup analyses to separate studies by those that in-
cluded post-discharge support and those that did not were
considered. However, due to the number imbalance (20
RCTs offered post-discharge support, whereas three did
not), the subgroup analysis was not conducted. A funnel
plot suggested the possibility of publication bias
(Supporting information, Fig. S1). Egger’s regression inter-
cept was significant, but no evidence of asymmetry was
seen when the trim-and-fill method was used (Supporting
information, Fig. S2).
Three cohort studies aimed to use biochemically veri-
fied abstinence. One study found all participants reported
smoking at the 3-month follow-up [9], and two did not re-
port findings of verified abstinence [62,67]. Ten cohort
studies reported self-reported abstinence [9,63–71].
Figure 4 presents abstinence rates (either self-reported or
biochemically verified in all intervention and control
groups) by longest follow-up length. Where studies had
the same follow-up length, the average value was calcu-
lated for abstinence rates.
Behaviour change techniques
Inter-rater coding reliability was high, with an average
agreement of 91% per intervention (range = 60–100%).
Supporting information, Table S3 presents BCTs identified
in each intervention arm in all studies. A total of 59 of
the 93 BCTs from the BCTTv1 were identified within inter-
ventions at least once across all studies (Supporting infor-
mation, Table S4). For control interventions (n = 27),
only four BCTs were identified at least once (Supporting
information, Table S5).
Focusing upon long-term effective interventions
[39,43,48,49,51,59,61] only, five of the six interventions
offered educational materials and counselling during the
stay, in addition to pharmacological support and/or further
behavioural support post-discharge. A total of 37 of the 93
BCTs were identified in at least one study. The number of
BCTs identified ranged from five to 36, with an average of
Figure 2 Comparison of biochemically verified abstinence at longest follow-up in randomized controlled trials (RCTs)
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10.7 BCTs per intervention. Table 1 presents the frequency
of BCTs in all long-term effective interventions (n = 7). The
most frequent BCTs were: ‘goal-setting (behaviour)’ (n=6);
‘pharmacological support’ (n = 6); ‘information about
health consequences’ (n = 5) and ‘action planning’
(n = 5). Similarly, the most frequent BCTs in control groups
were: ‘pharmacological support’ (n = 14) and ‘information
about health consequences’ (n = 7). Two control groups
delivered ‘social support (unspecified)’ and one delivered
‘problem-solving’.
Twelve BCTs were characterized as ‘promising’, or most
likely to enhance effectiveness of interventions to maintain
smoking abstinence (Table 1). Of those, nine were also de-
livered in ≥ 25% of all interventions, indicating their prom-
ise in terms of feasibility (Table 1).
Factors associated with/predictors of success or failure of
post-discharge smoking interventions
Forty-two factors associated with/predictors of success and
17 factors associated with/predictors of failure were identi-
fied by study authors. Of those 59 predictors, 37 were non-
modifiable (e.g. age, ethnicity, nicotine dependence, mental
health diagnosis). Six were modifiable, but related to a be-
haviour, rather than an influence on a behaviour (e.g.
the use of pharmacotherapy or behavioural support).
These were not coded to the TDF, as only modifiable influ-
ences on a behaviour (e.g. barriers/enablers) were coded,
rather than demographic factors or supporting behaviours.
The remaining 16 predictors weremodifiable (e.g. plans
to not smoke post-release or desire to quit), but four were
Figure 3 (a) Comparison of biochemically verified abstinence in randomized controlled trials (RCTs) with a follow-up length of below 6 months
(range = 4 weeks–6 months). (b) Comparison of biochemically verified abstinence in RCTs with a follow-up length of above 6 months
(range = 6.5 months–18 months)
Figure 4 Abstinence rates (%) in all intervention and control
arms (via self-report or biochemical validation), by longest
follow-up length
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Table 1 Behaviour change techniques (BCTs) identified as ‘promising’ in terms of probable effectiveness and feasibility.












Provide, or encourage the use of or
adherence to, drugs to facilitate
behaviour change
Patients were offered NRT during
hospitalization and were offered a
10-week course of NRT available at








Set or agree on a goal defined in terms of
the behaviour to be achieved
For smokers considering tobacco
abstinence after hospital discharge, the
counsellor conducted a standard
assessment and helped the smoker to









Provide information (e.g. written, verbal,
visual) about health consequences of
performing the behaviour
Physician informed patients about the
potential health risks of tobacco use and






Action planning Prompt detailed planning of performance
of the behaviour
Participants repeated the computer
intervention post-discharge, which
recommended next steps towards
smoking and maintaining abstinence






Problem-solving Analyse (or prompt the person to
analyse) factors influencing the
behaviour and generate or select
strategies that include overcoming
barriers and/or increasing facilitators
The counselling sessions provided
stage-tailored strategies for managing









Advise or agree on how to perform the
behaviour (includes ‘skills training’)
At discharge, all participants received a
pack of NRT and instructions for use








Advise on, arrange or provide emotional
social support for performance of the
behaviour
Automated interactive voice response
telephone calls provided support
messages that prompted smokers to quit,
and triaged smokers to a return
telephone call from a live counsellor for
additional support. The automated
telephone script encouraged participants
to request a call-back from a counsellor if
they had low confidence in their ability








Advise on, arrange or provide practical
help for performance of the behaviour
Patients could request a call from a
counsellor if they needed a medication
refill, had problems with a medication or









Advise on, arrange or provide social
support or non-contingent praise or
reward for performance of the behaviour.
It includes encouragement and
counselling, but only when it is directed
at the behaviour
An initial motivational interview used
the 5As method: ask about tobacco use,
advise to quit, assess willingness to quit,
assist towards a successful quit attempt









Monitor and provide informative or
evaluative feedback on performance of
the behaviour
Participants repeated the computer
intervention post-hospitalization which
stored their previous entries, providing
ipsative feedback on how they changed
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Table 1. (Continued)










Pros and cons Advise the person to identify and
compare reasons for wanting (pros) and
not wanting to (cons) change the
behaviour
The counselling provided motivational
enhancement and strategies for
managing temptations, considering the
pros and cons of change (decisional






Suggest the deliberate adoption of a
perspective or new perspective on
behaviour (e.g. its purpose) in order to
change cognitions or emotions about
performing the behaviour
Counsellors assessed the knowledge and
beliefs of the participant, as well as the
potential barriers to smoking cessation,
explained the mechanisms of nicotine
dependence and symptoms of
withdrawal, and presented
counter-arguments to belief barriers and
discussed behavioural self-management
strategies to counter triggers (Ferreira







Provide information about antecedents
(e.g. social and environmental situations
and events, emotions, cognitions) that
reliably predict performance of the
behaviour
c





Advise on how to avoid exposure to
specific social and contextual/physical
cues for the behaviour, including
changing daily or weekly routines.
c
1 (14.3) 12 (32.4)
Social reward Arrange verbal or non-verbal reward if
and only if there has been effort and/or
progress in performing the behaviour
c




Change, or advise to change the social
environment in order to facilitate
performance of the wanted behaviour or
create barriers to the unwanted
behaviour (other than prompts/cues,
rewards and punishments)
c
1 (14.3) 10 (27.0)
Focus on past
success
Advise to think about or list previous
successes in performing the behaviour (or
parts of it)
c
1 (14.3) 10 (27.0)
Prompts/cues Introduce or define environmental or
social stimulus with the purpose of
prompting or cueing the behaviour. The
prompt or cue would normally occur at
the time or place of performance
c




Change, or advise to change the physical
environment in order to facilitate
performance of the wanted behaviour or
create barriers to the unwanted
behaviour (other than prompts/cues,
rewards and punishments)
c




Establish a method for the person to
monitor and record their behaviour(s) as
part of a behaviour change strategy
c
1 (14.3) 9 (24.3)
(Continues)
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Table 1. (Continued)












Prompt substitution of the unwanted
behaviour with a wanted or neutral
behaviour
c




Prompt practice or rehearsal of the
performance of the behaviour one or
more times in a context or at a timewhen
the performancemay not be necessary, in
order to increase habit and skill
c
1 (14.3) 6 (16.2)
Self-talk Prompt positive self-talk (aloud or
silently) before and during the behaviour
c





Provide information (e.g. written, verbal,
visual) about social and environmental
consequences of performing the
behaviour
c
1 (14.3) 6 (16.2)
Self-reward Prompt self-praise or self-reward if and
only if there has been effort and/or
progress in performing the behaviour
c
1 (14.3) 5 (13.5)
Reduce negative
emotions
Advise on ways of minimizing demands
on mental resources to facilitate
behaviour change.
c
1 (14.3) 5 (13.5)
Body changes Alter body structure, functioning or
support directly to facilitate behaviour
change
c





Advise the person to construct a new
self-identity as someone who ‘used to
engage with the unwanted behaviour’
c




Advise to practice imagining performing
the behaviour successfully in relevant
contexts
c
1 (14.3) 5 (13.5)
Imaginary
reward
Advise to imagine performing the wanted
behaviour in a real-life situation followed
by imagining a pleasant consequence
c
1 (14.3) 5 (13.5)
Non-specific
reward
Arrange delivery of a reward if and only if
there has been effort and/or progress in
performing the behaviour
c
1 (14.3) 5 (13.5)
Incompatible
beliefs
Draw attention to discrepancies between
current or past behaviour and self-image,
in order to create discomfort
Counsellor presented
counter-arguments to belief barriers
(Ferreira Campos et al., 2018)
1 (14.3) 3 (8.1)
Commitment Ask the person to affirm or reaffirm
statements indicating commitment to
change the behaviour
c
1 (14.3) 3 (8.1)
Adding objects to
the environment
Add objects to the environment in order
to facilitate performance of the behaviour
c
1 (14.3) 3 (8.1)
Graded tasks Set easy-to-perform tasks, making them
increasingly difficult, but achievable,
until the behaviour is performed
c
1 (14.3) 2 (5.4)
Social
comparison
Draw attention to others’ performance to
allow comparison with the person’s own
performance.
c
1 (14.3) 2 (5.4)
Provide information about what other
people think about the behaviour. The
c
1 (14.3) 2 (5.4)
(Continues)
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not reported in sufficient detail to enable coding and inter-
pretation. For example, Hickman et al., [47] identified
thoughts about abstinence desire and success as a signifi-
cant predictor of abstinence, but reported no further infor-
mation. This could not be confidently coded based on the
level of detail provided. The 12 modifiable factors associ-
ated with/predictors of success that could be mapped on
to the TDF are presented in Table 2. All the predictors
mapped onto the domains ‘intentions’, ‘environmental
context and resources’ and ‘goals’were modifiable enablers
that were associated with a successful outcome. Con-
versely, the predictors that mapped onto the domains ‘be-
liefs about consequences’ and ‘emotion’ were modifiable
barriers to smoking cessation.
Experiences, needs or perceptions related to smoking
cessation support
Two cohort studies collected post-intervention data related
to participants’ perceptions or experiences of the interven-
tion [62,67]. Bernard et al., [62] reported that, overall, the
intervention was perceived positively by participants. All
participants were interested in receiving specific advice
from health professionals regarding reduction strategies
and nicotine replacement therapy (NRT), as well as to facil-
itate interactions with a peer: ‘training partner for support
is an advantage for coming in session’. Strong et al. [67] re-
ported that the participants’ experiences were positive, and
the elements most frequently described as being helpful
Table 1. (Continued)













information clarifies whether others will
like, approve or disapprove of what the
person is doing or will do
a
Indicates ‘promising’ BCTs in terms of probable effectiveness;
b
indicates ‘promising’ BCTs in terms of feasibility;
c
indicates BCTs identified in additional infor-
mation provided by an author contacted by Brose et al. While these BCTs were identified, examples were either not provided by Brose et al. or not provided
due to a confidentiality and non-disclosure agreement.
Table 2 Factors associated with/predictors of success mapped onto the TDF.
Domain label Definition of domain (Michie et al., 2014) Frequency (n) Study example
Intentions A conscious decision to perform a behaviour or a
resolve to act in a certain way
7 The likelihood of successful smoking cessation was
associated with a good motivation to quit
(P = 0.009) (Abroug et al., 2020)
Beliefs about
consequences
Acceptance of the truth, reality, or validity about
outcomes of a behaviour in a given situation
2 Perceived barriers to smoking cessation, primary
among which were concerns about weight gain




Any circumstance of a person’s situation or
environment that discourages or encourages the
development of skills and abilities, independence,
social competence, and adaptive behaviour
1 Reid et al., (2019) concluded that when support
and access to cessation assistance was extended
beyond hospital discharge, continuous abstinence
was improve
Goals Mental representations of outcomes or end states
that an individual wants to achieve
1 Patients with non-abstinence related goals (83%)
weremore likely to return to smokingon the dayof
discharge compared to those who endorsed the
goal of complete abstinence (58%, P = 0.016)
(Prochaska et al., 2006)
Emotion A complex reaction pattern, involving
experiential, behavioural and physiological
elements, by which the individual attempts to deal
with a personally significant matter or event
1 The perceived benefits of smoking cigarettes were
significantly and positively correlated with
endorsement of the first cigarette upon
post-release as expressing freedom (P = 0.048).
(Van den Berg et al., 2014)
TDF = Theoretical Domains Framework.
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were discussing techniques to quit or stay quit, receiving
referrals and having a copy of the change plan worksheet
completed by the therapist during the sessions.
Spontaneous comments collected during interviews in
one cohort study [65] indicated that post-smoke-free policy
patients found the hospital smoking ban acceptable, but
many resented the mandatory nature of the nicotine treat-
ment programme. Many participants reported limited sup-
port for smoking cessation post-discharge.
Three RCTs evaluated participant perceptions of an in-
tervention that included post-discharge contact via
text-messaging and telephone calls [41,57] or e-mail
[46]. The majority of participants (80%) reported that the
text message content was ‘helpful’, and 95% found tele-
phone calls to be ‘just the right length’ [41]. Almost all par-
ticipants (88%) recalled receiving e-mails, and
approximately half stated that they read the e-mails [46].
However, 70 participants added text comments, whereby
40% were negative, for example, ‘e-mails incessant’ or
‘don’t use computer’ [46]. Thorley et al. [57] reported that
both home visits and follow-up behavioural support, either
face-to-face or via telephone, were accepted by and deliv-
ered to > 70% of participants, and supportive telephone
calls, texts and NRT by > 50%. These components were
considered helpful by the majority of participants, whereas
uptake of referral to a local stop smoking service was very
low (< 2%).
One RCT collected data on the physician’s perceptions
of the E-STOPS intervention [38], an electronic support
tool to enhance providers’ treatment of adult smokers ad-
mitted to an acute hospital. Although a subset of physi-
cians (n = 21) perceived the benefit of E-STOPS, they had
specific suggestions for improvements (e.g. intervention
timing and additional support and training). Furthermore,
a few of the subset had concerns about the clinical appro-
priateness of beginning treatment for tobacco dependence
during hospitalization.
DISCUSSION
This review identified 37 studies investigating the mainte-
nance of smoking abstinence or cessation following a stay
in a smoke-free setting. There was evidence to suggest be-
havioural and pharmacological interventions were effec-
tive for improving abstinence, and 12 BCTs were
identified as ‘promising’ in terms of probable effectiveness.
Generally, studies delivered fewer BCTs post-discharge/re-
lease than during the stay, with the exception of eight tri-
als. These aimed to deliver a more complex intervention
following discharge [41,42,50–52,54,55,58]. Factors as-
sociated with/predictors of success or failure of smoking
cessation interventions were identified, building upon a
previous review [7]. These findings provide valuable data
for policymakers and settings that deliver smoking
cessation support, offering guidance about effective sup-
port and training needed for delivery of effective services.
Although the BCT analysis provides evidence on which
techniques are ‘promising’, it remains difficult to ascertain
any definitive conclusions regarding which techniques are
themost effective, as ameta-regressionwas not conducted.
While a meta-regression was considered, this was
discounted duemainly to the insufficient reporting of infor-
mation by study authors [72]. Descriptions of the BCTs
used in the published articles were often brief, and while ef-
forts were made to retrieve further information, the full
range of BCTs delivered may not have been captured in
all studies. The number of BCTs that could be coded varied
considerably between studies and was higher when
additional information (e.g. intervention manuals) was
provided by the study authors; a limitation also cited in
previous smoking cessation reviews [7]. Secondly,
subgroup analyses conducted in this review indicated less
heterogeneity when the studies were separated by trial
design, thus heterogeneity was accounted for [72]. Finally,
the current BCT analysis approach has been successfully
implemented in previous literature, including research
relating to smoking cessation [20,36]. Although these
previous studies included pregnant or postpartum
participants, there was a commonality of potentially
effective BCTs (e.g. ‘problem-solving’, ‘information about
health consequences’ and ‘social support’). Similarly, there
is a commonality of potentially effective BCTs previously
reported for the general population [73] and those with
mental health conditions [7], suggesting that the BCTs
identified in the current review as ‘promising’ in terms of
probable effectiveness may be applicable to a range of
populations.
The domains have been mapped to the BCT taxonomy
[74], facilitating comparison between the domains and rel-
evant BCTs. Several enablers of cessation (e.g. motivation
and plans to not smoke) were mapped onto the ‘intentions’
domain. Intentions have previously been reported as im-
portant barriers and facilitators to smoking cessation
[75], and a number of BCTs relating to goal-setting and ac-
tion planning, which could potentially help strengthen
one’s motivation to quit, were identified in this review. Fur-
thermore, one enabler was mapped onto the ‘goals’ do-
main. BCTs that target this domain include: ‘goal-setting
(behaviour)’ and ‘action planning’ [74,76]. These were
identified as ‘promising’ in this review, in terms of probable
effectiveness and feasibility. Additionally, they have been
previously associated with the effectiveness of behavioural
support interventions for smoking cessation [21,36,73].
One enabler relating to support and access to cessation
support after discharge wasmapped onto the ‘environmen-
tal context and resources’ domain. BCTs that target this do-
main include ‘prompts/cues’ and ‘avoidance/reducing
exposure to cues for the behaviour’ [74,76]. While these
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BCTs were delivered in a number of interventions identified
in this review, they were not characterized as ‘promising’.
This may, perhaps, explain why some interventions were
less effective, as they did not include BCTs to target key en-
ablers to cessation.
Conversely, barriers to cessation were mapped onto the
‘beliefs about consequences’ and ‘emotion’ domains. BCTs
that target these domains include ‘salience of conse-
quences’ and ‘social support (emotional)’ [74]. Although
‘salience of consequences’was not identified as ‘promising’
in the current review, ‘social support (emotional)’ was
identified as ‘promising’ in both terms of probable effective-
ness and feasibility. Social support has been identified as a
key component BCT in smoking cessation interventions
[21,73], and is known to be a key facilitator in preventing
relapse [77,78]. However, the magnitude of influence that
social networks have on smoking behaviour requires com-
plex action [79], and although social support was identified
as ‘promising’, this was due probably to many studies in-
volving support from smoking cessation specialists. A holis-
tic approach may be required, incorporating a number of
tailored techniques to involve a wider social network in
the cessation process [77].
The current findings advance our understanding of the
kind of behavioural and pharmacological support might
be effective for smoking cessation following a smoke-free
stay. The lack of evidence of a difference in abstinence
rates between short- and long-term follow-up should also
be noted. This may suggest that interventions that aim
to maintain abstinence may function differently to stan-
dard cessation interventions as risk of relapse reduces over
time and increased numbers of participants will have
maintained abstinence during their stay, resulting in more
stable effects earlier on [80]. Conversely, it is also possible
that the presence of wide CIs may disguise the difference
in abstinence rates between short- and long-term follow-
up. Even in the absence of difference in the various
follow-up periods, this does not provide information about
the overall risk of relapse; given that if relapse rates are
high but similar between groups, then RRs will remain
consistent over time.
Future interventions to maintain abstinence might in-
clude BCTs focused on goal planning, pharmacological sup-
port and social support to maximize effectiveness. Aligning
with the existing evidence base, these BCTs are often sug-
gested to be necessary for treating nicotine dependence
or developing a cessation plan [81]. However, even if inter-
ventions incorporate the same BCTs, implementation will
differ in terms of mode of delivery, frequency, quality and
adherence: factors that can all have an impact on the inter-
vention outcomes. Considering all the included studies, it
was unclear whether these characteristics related to the ef-
fectiveness of identified BCTs. Descriptions of intervention
characteristics and fidelity-related issues were restricted; a
limitation also noted in previous literature [82]. In addi-
tion, there was restricted information relating to partici-
pant compliance with smoke-free policies implemented
during their stay. As it is well known that compliance can
be limited and vary greatly between settings [83,84] this
factor should be considered, as it may effect smoking be-
haviour post-discharge and subsequently have an impact
upon intervention outcomes.
For continued smoking abstinence post-discharge/
release, many of the studies found evidence for positive
effects of education, counselling and pharmacological sup-
port, including those delivered remotely. Nearly half of all
included studies (n = 17) delivered remote support, includ-
ing computer-generated interventions or support via
telephone call or text messaging. It is important to consider
that some BCTs, however, may not be easily implemented
remotely. For example, it would be possible to implement
‘goal setting’ remotely by requesting a participant to select
a quit date [41], whereas other BCTs such as ‘biofeedback’
[57] could be challenging to deliver via an on-line platform
as it requires biochemical verification. Although there have
been emerging technologies and devices that enable
participants to conduct biochemical assessments remotely
[85,86], the cost of carbon dioxide (CO) monitors prohibits
widespread remote application [87]. Previous research has
also reported low compliance rates, as only 25% of partic-
ipants who self-reported abstinence submitted CO readings
remotely using a device that required connection to a
computer to function [88]. Recently, affordable
smartphone-enabled CO monitors have become available,
which may offer one low-cost option to biochemically ver-
ify smoking status remotely [87], and would be useful to
consider in the context of COVID-19-related research re-
strictions. Additionally, there has been an emergence of
smartphone applications (app.) as popular aids for smoking
cessation (e.g. the Smoke Free app.) [89]. As internet-based
support has been found in some cases to aid cessation [90],
smartphone apps can provide this functionality, with the
added advantage of being readily accessible [89]. However,
future interventions need to consider issues of implementa-
tion and acceptability within populations whomay be diffi-
cult to engage with via on-line methods.
Development and provision of effective interventions to
enable cessation or maintenance of abstinence after a
smoke-free stay is crucial to address smoking-related in-
equalities in vulnerable groups of smokers [7]. Behavioural
and pharmacological support is effective in maintaining
smoking abstinence following a smoke-free stay, but those
including BCTs focused upon goal planning, pharmacolog-
ical support and social support appear to be themost prom-
ising. Future research should evaluate interventions in
more diverse countries, policy settings and health and care
settings to investigate the potential impact of these contex-
tual differences.
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